These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27864438)

  • 21. Emerging bone problems in patients infected with human immunodeficiency virus.
    Mondy K; Tebas P
    Clin Infect Dis; 2003 Apr; 36(Suppl 2):S101-5. PubMed ID: 12652379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021.
    Ruan A; Tobin NH; Mulligan K; Rollie A; Li F; Sleasman J; Aldrovandi GM
    J Acquir Immune Defic Syndr; 2016 Aug; 72(4):372-5. PubMed ID: 26885808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.
    Bolland MJ; Grey AB; Horne AM; Briggs SE; Thomas MG; Ellis-Pegler RB; Woodhouse AF; Gamble GD; Reid IR
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):270-5. PubMed ID: 17547686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone disease in the setting of HIV infection: update and review of the literature.
    Castronuovo D; Cacopardo B; Pinzone MR; Di Rosa M; Martellotta F; Schioppa O; Moreno S; Nunnari G
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2413-9. PubMed ID: 24089217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects.
    Bongiovanni M; Fausto A; Cicconi P; Aliprandi A; Cornalba G; Bini T; Sardanelli F; D'Arminio Monforte A
    J Antimicrob Chemother; 2006 Aug; 58(2):485-6. PubMed ID: 16751202
    [No Abstract]   [Full Text] [Related]  

  • 26. Bone quality in perinatally HIV-infected children: role of age, sex, growth, HIV infection, and antiretroviral therapy.
    Rosso R; Vignolo M; Parodi A; Di Biagio A; Sormani MP; Bassetti M; Aicardi G; Bassetti D
    AIDS Res Hum Retroviruses; 2005 Nov; 21(11):927-32. PubMed ID: 16386108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of and risk factors for osteoporosis and fracture among a male HIV-infected population in the UK.
    Short CE; Shaw SG; Fisher MJ; Walker-Bone K; Gilleece YC
    Int J STD AIDS; 2014 Feb; 25(2):113-21. PubMed ID: 23970632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone changes and fracture risk in individuals infected with HIV.
    Warriner AH; Mugavero MJ
    Curr Rheumatol Rep; 2010 Jun; 12(3):163-9. PubMed ID: 20425517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative contribution of HIV infection, demographics and body mass index to bone mineral density.
    Cotter AG; Sabin CA; Simelane S; Macken A; Kavanagh E; Brady JJ; McCarthy G; Compston J; Mallon PW;
    AIDS; 2014 Sep; 28(14):2051-60. PubMed ID: 25265073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone alterations associated with HIV.
    Warriner AH; Mugavero M; Overton ET
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):233-40. PubMed ID: 25064454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of long-term highly active antiretroviral therapy on bone mineral density in HIV/AIDS patients].
    Su YB; Xie J; Han Y; Qiu ZF; Li YL; Song XJ; Yu W; Li TS
    Zhonghua Yi Xue Za Zhi; 2012 May; 92(17):1155-8. PubMed ID: 22883000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skeletal health in adults with HIV infection.
    Bolland MJ; Grey A; Reid IR
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):63-74. PubMed ID: 24731663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of bone mineral density in Iranian HIV/AIDS patients.
    Badie BM; Soori T; Kheirandish P; Izadyar S; SeyedAlinagh S; Foroughi M; Rostamian A; Mohraz M
    Acta Med Iran; 2011; 49(7):460-7. PubMed ID: 21960080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone disease in HIV infection: a practical review and recommendations for HIV care providers.
    McComsey GA; Tebas P; Shane E; Yin MT; Overton ET; Huang JS; Aldrovandi GM; Cardoso SW; Santana JL; Brown TT
    Clin Infect Dis; 2010 Oct; 51(8):937-46. PubMed ID: 20839968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone mass in HIV-infected patients: focus on the role of therapy and sex.
    Vescini F; Borderi M; Buffa A; Sinicropi G; Tampellini L; Chiodo F; Caudarella R
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):405-7. PubMed ID: 12843753
    [No Abstract]   [Full Text] [Related]  

  • 36. Adverse effects of antiretroviral therapy: focus on bone density.
    Viganò A; Mora S
    Expert Opin Drug Saf; 2004 May; 3(3):199-208. PubMed ID: 15155148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine complications of human immunodeficiency virus infection: hypogonadism, bone disease and tenofovir-related toxicity.
    Cotter AG; Powderly WG
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):501-15. PubMed ID: 21663843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Body composition in HIV-infected patients receiving highly active antiretroviral therapy.
    Chițu-Tișu CE; Barbu EC; Lazăr M; Bojincă M; Tudor AM; Hristea A; Abagiu AO; Ion DA; Bădărău AI
    Acta Clin Belg; 2017 Feb; 72(1):55-62. PubMed ID: 27724840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone mineral density increases in HIV-infected children treated with long-term combination antiretroviral therapy.
    Bunders MJ; Frinking O; Scherpbier HJ; van Arnhem LA; van Eck-Smit BL; Kuijpers TW; Zwinderman AH; Reiss P; Pajkrt D
    Clin Infect Dis; 2013 Feb; 56(4):583-6. PubMed ID: 23097583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic options for low bone mineral density in HIV-infected subjects.
    Cotter AG; Mallon PW
    Curr HIV/AIDS Rep; 2012 Jun; 9(2):148-59. PubMed ID: 22528765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.